Market Access Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point pharminent May 5, 2026
Market Access Flash Brief: PBM Reform Collides with MFN Pricing as Midterm Politics Reshape the Drug Pricing Landscape pharminent April 29, 2026
Market Access CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage pharminent April 23, 2026
Market Access Medicare weight loss drug pilot on ice as insurers decline to contribute pharminent April 22, 2026
Market Access Beyond GLP-1Rs: emerging targets poised to gain share of obesity market pharminent April 20, 2026
Market Access Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update pharminent April 14, 2026
Market Access Medicare Advantage Insurers Will See Higher Payments as CMS Backs Off a Key Payment Update pharminent April 8, 2026
Market Access The Big Three PBMs’ 2026 Formulary Exclusions: MFP, Private Label Biosimilars, and Direct-to-Patient Threats for PBMs (rerun) pharminent April 6, 2026
Market Access Insurers’ Prior Authorization Data Offers Little Insight Into What Gets Approved or Denied pharminent April 2, 2026
Market Access The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments pharminent March 30, 2026
